0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2028
Published Date: February 2019
|
Report Code: DELV-Epid-318
Home | Market Reports | Health | Reproductive Health
AIDS Related Kaposi Sarcoma Epidemiology Forecast to 2028

AIDS Related Kaposi's Sarcoma -Epidemiology Forecast to 2028

Code: DELV-Epid-318
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "AIDS Related Kaposi's Sarcoma  - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the AIDS Related Kaposi's Sarcoma  epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

 Study Period: 2016-2028

AIDS Related Kaposi's Sarcoma  Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for AIDS Related Kaposi's Sarcoma  in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the AIDS Related Kaposi's Sarcoma  outlook. It also includes the explanation of changing trends of epidemiology outlining the AIDS Related Kaposi's Sarcoma  scenario.

AIDS Related Kaposi's Sarcoma  Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the AIDS Related Kaposi's Sarcoma  thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of AIDS Related Kaposi's Sarcoma  explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The AIDS Related Kaposi's Sarcoma  Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
10 Year Forecast
• 7MM Coverage
• Total Cases in AIDS Related Kaposi's Sarcoma

Key assessments
Patient Segmentation in AIDS Related Kaposi's Sarcoma
• AIDS Related Kaposi's Sarcoma  Risk & Burden
• Factors driving growth in a specific AIDS Related Kaposi's Sarcoma  patient population

 

  1. Report Introduction
    2. AIDS Related Kaposi's Sarcoma Epidemiology Overview at a Glance
    2.1. Patient Share Distribution of AIDS Related Kaposi's Sarcoma in 2016
    2.2. Patient Share Distribution of AIDS Related Kaposi's Sarcoma in 2028
    3. Disease Background and Overview: AIDS Related Kaposi's Sarcoma
    3.1. Introduction
    3.2. Symptoms
    3.3. Etiology
    3.4. Risk Factors
    3.5. Pathophysiology
    3.6. Diagnosis
    3.7. Treatment
    4. Epidemiology and Patient Population
    4.1. Key Findings
    4.2. Total Prevalent/ Incident Patient Population of AIDS Related Kaposi's Sarcoma in 7MM
    4.3. Total Prevalent/ Incident Patient Population of AIDS Related Kaposi's Sarcoma in 7MM – By Countries
    5. Epidemiology of AIDS Related Kaposi's Sarcoma by Countries
    5.1. United States
    5.1.1. Assumptions and Rationale
    5.1.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.1.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma *
    5.1.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.1.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    5.2. EU5
    5.3. Assumptions and Rationale
    5.4. Germany
    5.4.1. Assumptions and Rationale
    5.4.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.4.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
    5.4.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.4.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    5.5. France
    5.5.1. Assumptions and Rationale
    5.5.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.5.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
    5.5.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.5.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    5.6. Italy
    5.6.1. Assumptions and Rationale
    5.6.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.6.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
    5.6.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.6.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    5.7. Spain
    5.7.1. Assumptions and Rationale
    5.7.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.7.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
    5.7.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.7.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    5.8. United Kingdom
    5.8.1. Assumptions and Rationale
    5.8.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.8.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
    5.8.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.8.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    5.9. Japan
    5.9.1. Assumptions and Rationale
    5.9.2. Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma
    5.9.3. Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma*
    5.9.4. Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma*
    5.9.5. Diagnosed Cases of the AIDS Related Kaposi's Sarcoma
    6. Unmet Needs of the AIDS Related Kaposi's Sarcoma
    7. Appendix
    8. Report Methodology
    8.1. Sources
    9. DelveInsight Capabilities
    10. Disclaimer
    11. About DelveInsight
    *Indication Specific

List of Table:

Table 1: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM
Table 2: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM by Countries
Table 3: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Table 4: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Table 5: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Table 6: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Table 10: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Table 12: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Table 13: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Table 14: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Table 15: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Table 18: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Table 22: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Table 24: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Table 25: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Table 26: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Table 30: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)

List of Figure:

Figure 1: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM
Figure 2: Total Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)*
Figure 6: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Figure 12: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Figure 13: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028) *
Figure 14: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028) *
Figure 26: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the AIDS Related Kaposi's Sarcoma in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and China Human Chorionic Gonadotropin Market Size Status and Forecast 2021 2027
Global and China Human Chorionic Gonadotropin Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-5P6782
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and Japan Shelf Pessary Market Insights Forecast to 2027
Global and Japan Shelf Pessary Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30R6480
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and Japan IVF Syringes Market Insights Forecast to 2027
Global and Japan IVF - Syringes Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-14M6743
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and United States Intrauterine Contraceptive Device Market Insights Forecast to 2027
Global and United States Intrauterine Contraceptive Device Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-12J6797
Sun Sep 05 00:00:00 UTC 2021

Add to Cart